Cargando…
ImmunoPET: Antibody-Based PET Imaging in Solid Tumors
Immuno-positron emission tomography (immunoPET) is a molecular imaging modality combining the high sensitivity of PET with the specific targeting ability of monoclonal antibodies. Various radioimmunotracers have been successfully developed to target a broad spectrum of molecules expressed by maligna...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273828/ https://www.ncbi.nlm.nih.gov/pubmed/35836956 http://dx.doi.org/10.3389/fmed.2022.916693 |
_version_ | 1784745161693069312 |
---|---|
author | Manafi-Farid, Reyhaneh Ataeinia, Bahar Ranjbar, Shaghayegh Jamshidi Araghi, Zahra Moradi, Mohammad Mobin Pirich, Christian Beheshti, Mohsen |
author_facet | Manafi-Farid, Reyhaneh Ataeinia, Bahar Ranjbar, Shaghayegh Jamshidi Araghi, Zahra Moradi, Mohammad Mobin Pirich, Christian Beheshti, Mohsen |
author_sort | Manafi-Farid, Reyhaneh |
collection | PubMed |
description | Immuno-positron emission tomography (immunoPET) is a molecular imaging modality combining the high sensitivity of PET with the specific targeting ability of monoclonal antibodies. Various radioimmunotracers have been successfully developed to target a broad spectrum of molecules expressed by malignant cells or tumor microenvironments. Only a few are translated into clinical studies and barely into clinical practices. Some drawbacks include slow radioimmunotracer kinetics, high physiologic uptake in lymphoid organs, and heterogeneous activity in tumoral lesions. Measures are taken to overcome the disadvantages, and new tracers are being developed. In this review, we aim to mention the fundamental components of immunoPET imaging, explore the groundbreaking success achieved using this new technique, and review different radioimmunotracers employed in various solid tumors to elaborate on this relatively new imaging modality. |
format | Online Article Text |
id | pubmed-9273828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92738282022-07-13 ImmunoPET: Antibody-Based PET Imaging in Solid Tumors Manafi-Farid, Reyhaneh Ataeinia, Bahar Ranjbar, Shaghayegh Jamshidi Araghi, Zahra Moradi, Mohammad Mobin Pirich, Christian Beheshti, Mohsen Front Med (Lausanne) Medicine Immuno-positron emission tomography (immunoPET) is a molecular imaging modality combining the high sensitivity of PET with the specific targeting ability of monoclonal antibodies. Various radioimmunotracers have been successfully developed to target a broad spectrum of molecules expressed by malignant cells or tumor microenvironments. Only a few are translated into clinical studies and barely into clinical practices. Some drawbacks include slow radioimmunotracer kinetics, high physiologic uptake in lymphoid organs, and heterogeneous activity in tumoral lesions. Measures are taken to overcome the disadvantages, and new tracers are being developed. In this review, we aim to mention the fundamental components of immunoPET imaging, explore the groundbreaking success achieved using this new technique, and review different radioimmunotracers employed in various solid tumors to elaborate on this relatively new imaging modality. Frontiers Media S.A. 2022-06-28 /pmc/articles/PMC9273828/ /pubmed/35836956 http://dx.doi.org/10.3389/fmed.2022.916693 Text en Copyright © 2022 Manafi-Farid, Ataeinia, Ranjbar, Jamshidi Araghi, Moradi, Pirich and Beheshti. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Manafi-Farid, Reyhaneh Ataeinia, Bahar Ranjbar, Shaghayegh Jamshidi Araghi, Zahra Moradi, Mohammad Mobin Pirich, Christian Beheshti, Mohsen ImmunoPET: Antibody-Based PET Imaging in Solid Tumors |
title | ImmunoPET: Antibody-Based PET Imaging in Solid Tumors |
title_full | ImmunoPET: Antibody-Based PET Imaging in Solid Tumors |
title_fullStr | ImmunoPET: Antibody-Based PET Imaging in Solid Tumors |
title_full_unstemmed | ImmunoPET: Antibody-Based PET Imaging in Solid Tumors |
title_short | ImmunoPET: Antibody-Based PET Imaging in Solid Tumors |
title_sort | immunopet: antibody-based pet imaging in solid tumors |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273828/ https://www.ncbi.nlm.nih.gov/pubmed/35836956 http://dx.doi.org/10.3389/fmed.2022.916693 |
work_keys_str_mv | AT manafifaridreyhaneh immunopetantibodybasedpetimaginginsolidtumors AT ataeiniabahar immunopetantibodybasedpetimaginginsolidtumors AT ranjbarshaghayegh immunopetantibodybasedpetimaginginsolidtumors AT jamshidiaraghizahra immunopetantibodybasedpetimaginginsolidtumors AT moradimohammadmobin immunopetantibodybasedpetimaginginsolidtumors AT pirichchristian immunopetantibodybasedpetimaginginsolidtumors AT beheshtimohsen immunopetantibodybasedpetimaginginsolidtumors |